Hierrodexina solution for injection

国: アルメニア

言語: 英語

ソース: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

有効成分:

iron polysaccharide, cobalt chloride, vitamin B12

から入手可能:

Invesa Industrial Veterinaria

ATCコード:

Կիրառելի չէ (QB03AC)

INN（国際名）:

iron polysaccharide, cobalt chloride, vitamin B12

投薬量:

100mg/ml+ 4mcg/ml+ 25mcg/ml

医薬品形態:

solution for injection

パッケージ内のユニット:

50ml and 100ml glass vial

処方タイプ:

Prescription

認証ステータス:

Registered

承認日:

2020-03-11

製品の特徴

HIERRODEXINA Injectable solution
SUMMARY OF PRODUCT CHARACTERISTICS (SPC)
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
HIERRODEXINA
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Each ml contains:
Active substances:
Iron (as iron dextran)
100 mg
Cobalt chloride
4

g
Vitamin B
12
25

g
Excipients:
For a full list of excipients, see section 6.1
3. PHARMACEUTICAL FORM
Solution for injection
4. CLINICAL PARTICULARS
4.1. TARGET SPECIES
Swine, Cattle and Sheep.
4.2. INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
- SWINE, CATTLE AND SHEEP
Treatment of hypochromic type anemia caused by iron deficiency,
especially
anemia
of
piglets.
It
is
used
to
increase
resistance
to
microbial
diseases
(pneumonia, diarrhea,...) during pregnancy, in periods of
convalescence, in cattle
piroplasmosis and in general as a tonic.
HIERRODEXINA Injectable solution
4.3. CONTRAINDICATIONS
Not described.
4.4. SPECIAL WARNINGS
If the injection is administered into the semitendinosus or
semimembranosus
muscles can cause injuries to the tibial and peroneal nerve, with
subsequent
loss of muscle tone.
4.5. SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Disinfect injection site prior to administration.
SPECIAL
PRECAUTIONS
TO
BE
TAKEN
BY
THE
PERSON
ADMINISTERING
THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
In case of self-injection or ingestion seek medical advice immediately
and show
the package leaflet or the label to the physician.
In case of contact with skin or eyes, wash with water.
4.6. ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
Coloration at the injection site.
Local reaction may occur as inflammation at the injection site, edema
and
necrosis.
4.7. USE DURING PREGNANCY, LACTATION OR LAY
No contraindications have been reported during these periods.
4.8.
INTERACTION
WITH
OTHER
MEDICINAL
PRODUCTS
AND
OTHER
FORMS
OF
INTERACTION
Do not administer simultaneously with oral iron preparations.
HIERRODEXINA Injectable solution
4.9. AMOUNTS TO BE ADMINISTERED AND ADMINISTRATION ROUTE
Deep intramuscular route.
-Piglets:
Prophylaxi